Skip to Content

Terumo Corp TRUMF

Morningstar Rating
$38.75 +1.42 (3.81%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TRUMF is trading at a 2% premium.
Price
$38.76
Fair Value
$26.67
Uncertainty
Medium
1-Star Price
$26.18
5-Star Price
$34.41
Economic Moat
Wnwrzt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TRUMF is a good fit for your portfolio.

Trading Information

Previous Close Price
$37.33
Day Range
$38.7538.75
52-Week Range
$24.9638.75
Bid/Ask
$37.21 / $38.98
Market Cap
$28.77 Bil
Volume/Avg
938 / 2,172

Key Statistics

Price/Earnings (Normalized)
34.96
Price/Sales
4.35
Dividend Yield (Trailing)
0.76%
Dividend Yield (Forward)
0.84%
Total Yield
1.27%

Company Profile

Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
30,207

Comparables

Valuation

Metric
TRUMF
NVRO
NUVA
Price/Earnings (Normalized)
34.9619.87
Price/Book Value
3.172.152.34
Price/Sales
4.351.441.79
Price/Cash Flow
23.3311.86
Price/Earnings
TRUMF
NVRO
NUVA

Financial Strength

Metric
TRUMF
NVRO
NUVA
Quick Ratio
1.034.880.60
Current Ratio
1.906.551.25
Interest Coverage
45.59−16.612.90
Quick Ratio
TRUMF
NVRO
NUVA

Profitability

Metric
TRUMF
NVRO
NUVA
Return on Assets (Normalized)
6.04%−9.42%4.87%
Return on Equity (Normalized)
8.50%−17.93%12.28%
Return on Invested Capital (Normalized)
7.08%−11.91%6.21%
Return on Assets
TRUMF
NVRO
NUVA
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncCfhm$137.3 Bil
BDX
Becton Dickinson & CoVkmhlr$71.1 Bil
ALC
Alcon IncSynyht$39.4 Bil
CLPBY
Coloplast A/S ADRFsdrp$29.8 Bil
RMD
ResMed IncCbfhpb$27.1 Bil
WST
West Pharmaceutical Services IncJwkbn$26.9 Bil
BAX
Baxter International IncPtlctv$21.6 Bil
COO
The Cooper Companies IncBxylgv$19.2 Bil
HOLX
Hologic IncLzgyll$17.9 Bil
TFX
Teleflex IncTdt$11.2 Bil

Sponsor Center